£105.16

Academic Press Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders

Price data last checked 60 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 24 days • 24 data points (No recent data available)

Historical
Generating forecast...
£105.82 £105.09 £105.25 £105.41 £105.57 £105.73 £105.89 01 February 2026 06 February 2026 12 February 2026 18 February 2026 24 February 2026

Price Distribution

Price distribution over 24 days • 2 price levels

Days at Price
Current Price
23 days · current 1 day 0 6 12 17 23 £105 £106 Days at Price

Price Analysis

Most common price: £105 (23 days, 95.8%)

Price range: £105 - £106

Price levels: 2 different prices over 24 days

Description

Overexpression of receptor tyrosine kinases (RTKs) has been implicated in cancer. Increasing evidence suggests that dysregulation of RTKs is reported in many neurodegenerative and psychiatric disorders. Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders provides a fundamental, pragmatic map of RTKs structure, activation, functions, mechanism of action, gene regulation, and signaling pathways in developing central nervous system (CNS), adult normal CNS, neurodegenerative and psychiatric disorders. Additionally, the structure, function, activation, and therapeutic potential of many growth factors have been covered. Here, international experts in the field offer a comprehensive discussion of results of pre-clinical and clinical studies of repositioning of anti-cancer receptor tyrosine kinase inhibitors (RTKIs) and other promising protein kinase inhibitors in various neurodegenerative disorders including, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis, and psychiatric disorders including, anxiety, depression, alcohol use disorder, and schizophrenia. In addition, the book discusses the obstacles and opportunities for the potential repositioning of kinase inhibitors in neurodegenerative and psychiatric disorders. Provides a thorough overview of RTKs biology and their role in health and disease progression and modulation Highlights RTK families and the numerous receptors within each subfamily Examines RTKIs and other protein kinase inhibitors in pre-clinical and clinical trials in both neurodegenerative and psychiatric disorders Gives future directions of possible safe effective targeted RTKIs and other protein kinase inhibitors that may be repositioned in various neurodegenerative and psychiatric disorders Includes chapter contributions from renowned experts in biology, pharmacology, neurology, psychiatry, and oncology

Key Features

New Store Stock

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
15 June 2023
Listed Since
19 January 2023

Barcode

No barcode data available

Similar Products You Might Like

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors
95% match

Trace Amines and Neurological Disorders: Potential Mechanisms and Risk Factors

Academic Press

£90.29 28 Mar 2026
Receptor Tyrosine Kinases: Structure, Functions and Role in Human Disease
94% match

Receptor Tyrosine Kinases: Structure, Functions and Role in Human Disease

Springer

£108.78 11 Mar 2026
A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics
94% match

A Review on Diverse Neurological Disorders: Pathophysiology, Molecular Mechanisms, and Therapeutics

Academic Press

£166.67 07 Mar 2026
Receptor Tyrosine Kinases: Family and Subfamilies
94% match

Receptor Tyrosine Kinases: Family and Subfamilies

Springer

£142.97 26 Jan 2026
Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders
94% match

Neurobiology of Brain Disorders: Biological Basis of Neurological and Psychiatric Disorders

Academic Press

£90.46 12 Jan 2026
Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)
94% match

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Springer

£95.63 10 Mar 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
93% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Academic Press

£52.49 21 Feb 2026
Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)
93% match

Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)

CRC Press

£71.95 28 Feb 2026
Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)
93% match

Isoquinolines And Beta-Carbolines As Neurotoxins And Neuroprotectants: New Vistas In Parkinson's Disease Therapy: 1 (Current Topics in Neurotoxicity, 1)

Springer

£82.66 19 Dec 2025
Enzymes in Neurodegenerative Disorders: Mechanism and Therapeutic Potentials
93% match

Enzymes in Neurodegenerative Disorders: Mechanism and Therapeutic Potentials

£127.00 08 Jan 2026
Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)
93% match

Drug Repositioning: Approaches and Applications for Neurotherapeutics (Frontiers in Neurotherapeutics Series)

CRC Press

£97.00 08 Mar 2026
5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)
93% match

5-HT2C Receptors in the Pathophysiology of CNS Disease: 22 (The Receptors, 22)

Humana

£145.63 10 Mar 2026
The American Psychiatric Association Publishing Textbook of Neuropsychiatry and Clinical Neurosciences
93% match

The American Psychiatric Association Publishing Textbook of Neuropsychiatry and Clinical Neurosciences

American Psychiatric Association Publishing

£150.83 13 Jan 2026
Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)
93% match

Molecular Biology of Neuropsychiatric Disorders: 23 (Nucleic Acids and Molecular Biology, 23)

Springer

£118.00 18 Apr 2026
Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)
93% match

Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)

Springer

£105.19 27 Feb 2026
Neuroleptic-induced Movement Disorders: A Comprehensive Survey
93% match

Neuroleptic-induced Movement Disorders: A Comprehensive Survey

Cambridge University Press

£86.79 08 Mar 2026
Neuroscience for Psychologists and Other Mental Health Professionals: Promoting Well-Being and Treating Mental Illness
93% match

Neuroscience for Psychologists and Other Mental Health Professionals: Promoting Well-Being and Treating Mental Illness

Springer Publishing Company

£60.99 18 Mar 2026
Advances in Neuropharmacology: Drugs and Therapeutics
93% match

Advances in Neuropharmacology: Drugs and Therapeutics

CRC Press

£76.70 17 Mar 2026
The Molecular and Cellular Basis of Neurodegenerative Diseases: Underlying Mechanisms
93% match

The Molecular and Cellular Basis of Neurodegenerative Diseases: Underlying Mechanisms

Academic Press

£66.45 12 Jan 2026
Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies
93% match

Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies

Academic Press

£51.20 13 Feb 2026
Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)
93% match

Protein Tyrosine Kinases: From Inhibitors to Useful Drugs (Cancer Drug Discovery and Development)

Humana

£141.86 19 Feb 2026
Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
93% match

Molecular Mechanisms of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Humana

£143.46 23 Jan 2026
Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites
93% match

Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites

Springer

£91.63 09 Mar 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
93% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.02 09 Mar 2026